Literature DB >> 9547002

Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.

J J Kazama1, M Arakawa, F Gejyo.   

Abstract

Dialysis related amyloidosis (DRA) is a major complication of long term hemodialysis therapy. It is well recognized that scintigraphic study using radioisotope-labeled beta 2-microglobulin (beta 2M) as a tracer is a sensitive and specific technique to diagnose DRA non-invasively. The aim of this study is to clarify the mechanism of 131I-beta 2M accumulation around the amyloid tissue. Three dialysis patients with carpal tunnel syndromes were examined for consecutive 131I-beta 2M scintigraphies every 24 hours for 3 days till the carpal tunnel synovectomy. Removed synovial tissues were processed for histological study. The scintigraphic study demonstrated tracer accumulations in the joints involved with DRA and the intensity increased in a time dependent fashion. Microscopic observations revealed many inflammatory cells presenting CD68-monocytes/macrophages antigen infiltrated into the synovial tissues. 131I-beta 2M was evident in the cytoplasm of the infiltrating cells, while no radioactivity was detected above background in the amyloid tissues. In conclusion, the tracer accumulations observed in the 131I-beta 2M scintigraphic studies were the consequence of circulating beta 2M assimilated by the infiltrating monocytes/macrophages. Thus, the undetermined elimination pathway of circulating beta 2M in the dialysis patients was identified as the storage pool in those inflammatory cells. The inflammatory change may play a crucial role in the local progression of DRA through the accumulation of circulating beta 2M around the established amyloid tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547002     DOI: 10.3109/13506129809007286

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  1 in total

Review 1.  Abeta-2M-amyloidosis and related bone diseases.

Authors:  Junichiro James Kazama; Suguru Yamamoto; Naoki Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.